Reaction
Vascular Device Occlusion reporting signals
As of the last recalculation, Vascular Device Occlusion appears in 332 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 87.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 14 | 87.8 | 87.9 |
| Epoprostenol | 17 | 85.8 | 85.9 |
| Teduglutide | 16 | 78.2 | 78.3 |
| Treprostinil | 97 | 68.0 | 68.1 |
| Macitentan | 54 | 58.2 | 58.2 |
| Riociguat | 26 | 54.2 | 54.2 |
| Sildenafil | 33 | 39.5 | 39.6 |
| Tadalafil | 47 | 34.1 | 34.1 |
| Ambrisentan | 44 | 25.3 | 25.3 |